WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
+12.81%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$18.9B
AUM Growth
+$3.55B
(+23%)
Cap. Flow
+$2.5B
Cap. Flow
% of AUM
13.19%
Top 10 Holdings %
Top 10 Hldgs %
14.56%
Holding
1,090
New
199
Increased
468
Reduced
192
Closed
179
Top Buys
| 1 |
Microsoft
MSFT
|
$247M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$152M |
| 3 |
Brown & Brown
BRO
|
$120M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
$113M |
| 5 |
Akero Therapeutics
AKRO
|
$106M |
Top Sells
| 1 |
Lam Research
LRCX
|
$144M |
| 2 |
MetLife
MET
|
$97.2M |
| 3 |
Travelers Companies
TRV
|
$91.9M |
| 4 |
Electronic Arts
EA
|
$91.9M |
| 5 |
SWTX
SpringWorks Therapeutics
SWTX
|
$80.3M |
Sector Composition
| 1 | Healthcare | 25.08% |
| 2 | Technology | 24.07% |
| 3 | Financials | 10.59% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Industrials | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
776
TKO Group
TKO
$16.5B
| $1.32M | 0.01% |
+7,242
| New | +$1.32M |
|
777
Healthpeak Properties
DOC
$12.7B
| $1.32M | 0.01% |
75,149
+16,046
| +27% | +$281K |
|
|
MNTN
778
MNTN, Inc.
MNTN
$1.45B
| $1.31M | 0.01% |
+60,000
| New | +$1.31M |
|
779
Domino's
DPZ
$15.8B
| $1.31M | 0.01% |
2,909
-82,795
| -97% | -$37.3M |
|
780
Fox Class A
FOXA
$27.8B
| $1.3M | 0.01% |
23,152
-631,565
| -96% | -$35.4M |
|
781
Prologis
PLD
$105B
| $1.28M | 0.01% |
+12,198
| New | +$1.28M |
|
782
Repligen
RGEN
$6.79B
| $1.28M | 0.01% |
10,268
-45,938
| -82% | -$5.71M |
|
783
Neurogene
NGNE
$278M
| $1.25M | 0.01% |
83,835
+425
| +0.5% | +$6.35K |
|
784
Insulet
PODD
$24.6B
| $1.24M | 0.01% |
+3,936
| New | +$1.24M |
|
785
C.H. Robinson
CHRW
$14.9B
| $1.23M | 0.01% |
12,843
+2,814
| +28% | +$270K |
|
786
News Corp Class A
NWSA
$16.9B
| $1.21M | 0.01% |
+40,802
| New | +$1.21M |
|
787
Alexandria Real Estate Equities
ARE
$14.6B
| $1.21M | 0.01% |
16,654
+3,639
| +28% | +$264K |
|
788
Mineralys Therapeutics
MLYS
$2.79B
| $1.19M | 0.01% |
87,868
+40,206
| +84% | +$544K |
|
789
Ralph Lauren
RL
$18.7B
| $1.18M | 0.01% |
4,309
+940
| +28% | +$258K |
|
790
Pinnacle West Capital
PNW
$10.5B
| $1.15M | 0.01% |
12,899
+3,293
| +34% | +$295K |
|
791
Nurix Therapeutics
NRIX
$742M
| $1.14M | 0.01% |
100,271
+67
| +0.1% | +$763 |
|
792
Solventum
SOLV
$12.9B
| $1.14M | 0.01% |
14,973
+3,296
| +28% | +$250K |
|
793
J.M. Smucker
SJM
$11.9B
| $1.13M | 0.01% |
11,511
+2,521
| +28% | +$248K |
|
794
Terns Pharmaceuticals
TERN
$637M
| $1.13M | 0.01% |
301,612
| – | – |
|
795
Parker-Hannifin
PH
$96.3B
| $1.11M | 0.01% |
1,588
-26,618
| -94% | -$18.6M |
|
|
BBOT
796
BridgeBio Oncology Therapeutics, Inc. Common Stock
BBOT
$872M
| $1.1M | 0.01% |
103,247
| – | – |
|
797
Stoke Therapeutics
STOK
$1.2B
| $1.08M | 0.01% |
95,120
| – | – |
|
|
JBIO
798
Jade Biosciences, Inc. Common Stock
JBIO
$244M
| $1.06M | 0.01% |
+106,270
| New | +$1.06M |
|
799
EQT Corp
EQT
$31.7B
| $1.06M | 0.01% |
18,165
-500,773
| -96% | -$29.2M |
|
800
Conagra Brands
CAG
$9.32B
| $1.06M | 0.01% |
51,635
+11,309
| +28% | +$231K |
|